Matt Mandel, MD

Matt Mandel, MD has a diverse work experience in the field of clinical development and medical affairs. Matt is currently serving as the VP of Clinical Development at BioXcel Therapeutics, Inc. where they oversee the entire lifecycle of clinical trials and provides medical monitoring activities. Prior to this, they worked as the VP of Clinical Development & Medical Affairs at RG Therapeutics Corp., where they played a key role in designing and authoring the company's Clinical Development Plan and filed a patent with USPTO for their discovery compounds.

Dr. Mandel also has experience as a Senior Medical Director at EMD Serono, Inc., where they headed the clinical team for a Phase 3 clinical trial in multiple sclerosis (MS) and was responsible for designing clinical trials and overseeing the analysis of clinical data. Matt has also held the position of Senior Medical Director at Sunovion Pharmaceuticals, where they developed and executed the US Medical Affairs strategy for the psychiatry franchise.

In addition, Dr. Mandel has worked at Sanofi Genzyme as a Senior Medical Director, where they led the global medical strategy for Aubagio (teriflunomide) and provided medical expertise for data generation and dissemination. Matt also served as a Medical Director in the US Medical Affairs team, successfully launching Aubagio in the US. Earlier in their career, they worked as an Associate Medical Director at EMD Serono, Inc., overseeing the neuroimmunology franchise and developing Human Factors Studies for medical device approval.

Dr. Mandel has a strong academic background, including roles as a Neurologist at Mount Sinai School of Medicine and a Resident in Neurology at Columbia University Medical Center. Matt has also worked as an Intern in Internal Medicine at NYU Medical Center and completed a fellowship in Neurovirology & Immunology at the National Institutes of Health (NIH).

Overall, Dr. Mandel's work experience showcases their expertise in clinical development and medical affairs, with a focus on multiple sclerosis and psychiatry. Matt has shown leadership skills in overseeing clinical trials, developing strategies, and collaborating with cross-functional teams.

Matt Mandel, MD obtained their Doctor of Medicine (MD) degree from NYU Grossman School of Medicine. Prior to that, they earned a Bachelor of Science (BS), summa cum laude, from Cornell University. Matt holds additional certifications in Neurology from the American Board of Psychiatry and Neurology, Inc., and in Medicine and Surgery from the New York State Education Department - Office of the Professions.